Item 2.02 Results of Operations and Financial Condition

On February 24, 2020, Epizyme, Inc., a Delaware corporation (the "Company") announced its financial results for the quarter and year ended December 31, 2019. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information provided under Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits




  99.1       Press release issued by the Company on February 24, 2020*

  104      Cover Page Interactive Date File (embedded within Inline XBRL document)

* The exhibit shall be deemed to be furnished, and not filed.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses